SGMS Archives - Blue Horseshoe Stocks

Blue Horseshoe Stocks: Fresh PBR Options & More

Petroleo Brasileiro SA (Petrobras) PBR – Recap

One of the ideas we had formulated toward the end of last week was the PBR Weekly $14 & 14.50 Calls. We mentioned in Friday morning’s premarket report that we expected the already solid gains we had seen the previous session to be expanded upon, and our assumption was accurate.

We saw epic new highs out of both of our tracked sets of contracts. The $14 Calls from our observed low of .21 on Thursday, saw a new high of .78 Friday for a two-day run of 271% The $14.50’s, which we had caught at a low of .05, ran to .29 for an impressive 480% move over the same span.

Updated Idea:
We’re going to update our idea to some weekly calls for this week and roll up our strike range. Provided PBR can hold its 50DMA of 14.32, we’ll be looking to the PBR Weekly $14.50-15.50 Calls.

Extended Watchlist Recaps:

We’ve been doing things the same way for several years now, issuing our daily ‘Extended Watchlist’ for ideas that don’t get featured, but are stil noteworthy enough to keep watch over. Two such plays that we’ve recently signaled came away from last week with some decent progress.

Epizyme, Inc. EPZM – EPZM was included in Friday’s extended watchlist and it had a very nice intraday push, helped along by solid jobs numbers which led to a good day for the markets as a whole. EPZM traded in a range from 6.40 up to 8.19, a solid 28% jump.
____

Scientific Games Corp. SGMS – On December 14th we included SGMS in our premarket report, and it has made steady and significant headway since that time, trading up from a low of 14.79 to a new high of 19.43 on Friday. A 31% move in a stock in this price range is a pretty darn good move through a few weeks of the holiday season. We’ll continue to keep an eye on this, which has become a solid momentum mover.

Extended Watchlist:
SAGE, INSM, QEP, ROKU, KEG, SPWR, AXSM, DXCM, SXTC,

Blue Horseshoe Stocks: SPY Puts

SPDR S&P500 ETF (SPY)

With a bearish market pattern continuing to emerge, we have to be ready to roll with the punches as best we can and use whatever momentum we can find, whether it’s upward or downward. Traditionally, the SPY has been our go-to in these kinds of instances.

It was just Tuesday morning that we signaled a range of five SPY Calls, which all produced big-time gain opportunities this midweek, ranging from 184-245% Now, with the markets looking to pull back once again, we’ll hop right to the other side of the fence and zero in on some SPY Puts to close out the week.

The targets that we’re going to be monitoring today are going to be the SPY Weekly $263.50-262 Puts*, which should work out nicely for possible quick-strike daytrades in the event that the premarket trends we’re observing do persist.

*NEVER trade options with a weekly expiration on a Friday unless you are an advanced level trader working with disposable funds.

Extended Watchlist:
ALQA, SGMS, EYES, DFFN, BEL, WPM

Blue Horseshoe Stocks: Momentum Play & More

Vision Plasma Systems, Inc. VLNX

We’ve got a sub-penny momentum play on our hands this morning in the form of VLNX. This volatile trader has been swinging violently over the past few months, sometimes more than a hundred percent at a time.

We’re going to have our eyes on VLNX as we close the book on another trading week; the stock came from beneath .001 yesterday and began to run, hitting a daily high of .0017. As you can see on the included chart below, a move past that point would open the door on much larger gains.

When VLNX has surged in recent months, it has routinely peaked in the .002-.004 range. A run back to those levels from here would provide a good chance for quick profits, and chart indicators are showing a forthcoming spike to be a distinct possibility.

FTE Networks, Inc. FTNW

We saw some action from FTNW after including it in yesterday’s report, as the stock offered up the opportunity for modest gains on the order of 23% intraday from .0303 to .04.

While the chart data shows that the stock hit highs in the .055-.065 range, those were what we refer to as “fat-finger prints”; blocks of such small volume so as to make them insignificant, since it would have been impossible to exit any sizable position at those prices.

Still, gains of up to 23%, which were possible, are nothing to thumb your nose at.

Extended Watchlist:
SGMS, ARNA, FSI, ARRY, PBR($16 calls for next week)

Blue Horseshoe Stocks: PBR, ACHN, TMSH & More

Petroleo Brasiliero S.A. (Petrobras) PBR

We’ll kick things off this morning with PBR once again, as the stock had another banner day and behaved very much like we suggested it might. Yesterday we mentioned that the PBR chart was looking ripe for further northward movement and that’s just what we got.

The stock itself broke back over $15, which led to some prime opportunities in each and every set of options contracts that we outlined in our morning report. We said we’d be looking at Weekly Calls from $14-$15 for quick-flip intraday opportunities, and they all offered up some serious gains.

The $14 Calls traded from .74 to as high as 1.09, a chance for traders to score up to 47% in profits. The $14.50’s made a nice move up from .34 to .75, good for a nice double-bagger and more at +120% The $15’s fared extremely well also, running a whopping 290% from .11 up to .43.

Even our contracts of longer-term interest, the 07/19 $15 Calls (which we caught at a low of .25) made a solid intraday move from .54-.84, a highly respectable 55% increase.

All in all, for options traders, PBR was a paradise on Monday, and we’ll be continuously monitoring the situation as the week progresses. Major areas of resistance appear on the chart at 15.50 and 15.85, so failure to pierce through that channel would certainly be a signal to us to take profits off of the table. In order to keep our interest levels high, PBR will need to maintain support above the 15-dollar mark.

Achillion Pharmaceuticals, Inc. ACHN

Appearing in yesterday’s extended watchlist, ACHN was another play with potential to start off a new week. After a significant morning gap-up, the stock would touch a low of 3.72 before running as high as 4.82, an intraday move of 30%

This morning the company came with a well-timed release concerning its Hep-C drug, and the stock continues to blow its top. The high this morning in premarket trading is 6.47, making ACHN one that we’ll definitely be interested to follow. Per this morning’s PR, there’s a timeline for the testing of this drug leading all the way up to the end of the year, so we’ll stick ACHN on our longer-term radar as well.

NEW HAVEN, Jun 10, 2014 (GLOBE NEWSWIRE via COMTEX) — Initial cohort of HCV-infected patients begin dosing with ACH-3422 for seven days. Clinical trials may continue evaluating 200 mg of sovaprevir for HCV-infected patients. Timelines for reporting proof-of-concept results with ACH-3422, a proprietary uridine-analog nucleotide polymerase inhibitor, during the fall of 2014 and initiating all-oral combination studies by the end of 2014 remain on track >>> FULL PR

TransGlobal Assets, Inc. TMSH

We’ve been following TMSH since last week, and have not been disappointed. The stock has played out a textbook dip-and-rip scenario for the last three sessions straight, offering up many opportunities to make gains.

Yesterday, it came down as low as .0079 before ripping its way up to .0128, a healthy intraday increase of 62% Provided it continues to trade in this manner, we’ll be looking to take advantage of any similar swings to the ones we’ve seen already. We want to see it make higher lows, and break through the channel of resistance between the previous two sessions’ swing highs (.0128-.0139).

Side Note:

Even with so much else to talk about today, we can’t forget about another cash cow in Apple. AAPL Calls have been providing us with some excellent opportunities in recent weeks as well, and we’re still highly attuned to that situation as well.

Extended Watchlist:
DNAX, SPEX, AVNR, SGMS, ATEA, TPLM, KNDI